PHASE-II CLINICAL-STUDY OF HIGH-DOSE TOREMIFENE IN PATIENTS WITH ADVANCED BREAST-CANCER

被引：8
|
作者：
MODIG, H
BORGSTROM, S
NILSSON, I
WESTMAN, G
机构：
[1] MALMO GEN HOSP,DEPT ONCOL,S-21401 MALMO,SWEDEN
[2] OREBRO REG HOSP,DEPT ONCOL,OREBRO,SWEDEN
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期
关键词：
D O I：
10.1016/0022-4731(90)90015-K
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thirteen postmenopausal women with advanced local or metastatic breast cancer were treated with the antiestrogen toremifene at a daily dose of 200 mg. All patients had failed previous treatment with different types of endocrine therapy and/or cytotoxic drugs. Objective response was only seen in one patient. Treatment was usually well tolerated but in three cases the drug had to be withdrawn due to side effects. © 1990.
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [41] VINDESINE - A PHASE-II TRIAL IN ADVANCED BREAST-CANCER PATIENTS
    ROBINS, HI
    TORMEY, DC
    SKELLEY, MJ
    FALKSON, G
    CROWLEY, JJ
    RAMIREZ, G
    FALKSON, H
    CANCER CLINICAL TRIALS, 1981, 4 (04) : 371 - 375
  • [42] PHASE-II STUDY OF ORAL IDARUBICIN IN ELDERLY PATIENTS WITH ADVANCED BREAST-CANCER
    CHEVALLIER, B
    MONNIER, A
    METZ, R
    NAMER, M
    MARTY, M
    ROCHE, H
    BASTIT, P
    HURTELOUP, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (05): : 436 - 439
  • [43] A PHASE-II STUDY OF 4-DEOXYDOXORUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER
    RANKIN, EM
    KNIGHT, RK
    RUBENS, RD
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 124 - 124
  • [44] ELLIPTINIUM - PHASE-II STUDY IN ADVANCED MEASURABLE BREAST-CANCER
    TREAT, J
    GREENSPAN, A
    RAHMAN, A
    MCCABE, MS
    BYRNE, PJ
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) : 231 - 234
  • [45] MULTICENTER PHASE-II STUDY OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED BREAST-CANCER
    CODY, R
    STEWART, D
    DEFORNI, M
    MOORE, M
    DALLAIRE, B
    AZARNIA, N
    GYVES, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (06): : 526 - 528
  • [46] LYMPHOBLASTOID INTERFERON IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
    NASO, C
    SIMONI, C
    MERLINI, L
    ROSSO, M
    PRONZATO, P
    REPETTO, L
    GARDIN, G
    ROSSO, R
    JOURNAL OF CHEMOTHERAPY, 1993, 5 (04) : 258 - 261
  • [47] MITOZOLOMIDE PHASE-II STUDY IN ADVANCED COLORECTAL AND BREAST-CANCER
    HERAIT, P
    ROUGIER, P
    MAYLEVIN, F
    FONTANA, X
    HAYAT, M
    ARMAND, JP
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 73 - 73
  • [48] PHASE-II STUDY OF LONIDAMINE (LDM) IN ADVANCED BREAST-CANCER
    不详
    ANTICANCER RESEARCH, 1986, 6 (03) : 392 - 392
  • [49] HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE (HD-EC) IN ADVANCED BREAST-CANCER - FINAL RESULTS OF A DOSE FINDING STUDY AND PHASE-II TRIAL
    MARSCHNER, N
    NAGEL, GA
    BEYER, JH
    ADLER, M
    AMMON, A
    ONKOLOGIE, 1990, 13 (04): : 272 - 278
  • [50] HIGH-DOSE TOREMIFENE FOR ESTROGEN AND PROGESTERONE-RECEPTOR NEGATIVE METASTATIC BREAST-CANCER - A PHASE-II TRIAL OF THE CANCER AND LEUKEMIA GROUP-B (CALGB)
    PERRY, JJ
    BERRY, DA
    WEISS, RB
    HAYES, DM
    DUGGAN, DB
    HENDERSON, IC
    BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (01) : 35 - 40
12345